Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07422584 · ClinicalTrials.gov registry record
Cytokine Response to Abdominal Wall Reconstruction
A clinical trial of Incisional Ventral Hernia, sponsored by Northwestern University.
- Recruiting
- Registry status
- 25
- Enrollment target
- 1
- Study location
NCT07422584: Recruiting study of Incisional Ventral Hernia, sponsored by Northwestern University.
NCT07422584 is a study of Incisional Ventral Hernia that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 25 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07422584, a study of Incisional Ventral Hernia, is actively recruiting participants, sponsored by Northwestern University.
- RECRUITING
- Registry status
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biologic and physiologic consequences of high-tension closure. The study includes three cohorts: 1) Healthy controls (N=5), 2) High-tension fascial closure AWR patients (N=10), 3) Low-tension fascial closure AWR patients (N=10). Fascial closure tension will not be altered for the purpose of the study and will be determined by the operating surgeon as part of routine clinical decision-making.
Primary Outcome
Blood and peritoneal fluid will be collected at baseline (intra-operative), immediately following fascial closure and on postoperative days 1, 3, and 5. Serum cytokine concentrations of GM-CSF, IFN-gamma, IL-1, IL-2, IL-5, IL-6, IL-8, and TNF-alpha (inflammatory); IL-4 and IL-10 (anti-inflammatory) will be measured via multiplex immunoassays (Luminex). Cytokine area under the curve will also be calculated to allow analysis of total cytokine exposure over time.
Conditions Studied
Interventions
- OTHER Not applicable- observational study
Study Locations (1)
Illinois
- Northwestern Memorial Hospital - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2026-02-03 |
| Est. Completion | 2027-03-05 |
What NCT07422584 shows while recruiting
NCT07422584 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 25 participants, a relatively small participant target.
The record links to 1 condition, with Incisional Ventral Hernia appearing as the primary indexed condition, and to 1 intervention - of which Not applicable- observational study is the first listed.
NCT07422584 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT07422584 about?
NCT07422584 is a clinical study titled "Cytokine Response to Abdominal Wall Reconstruction". This is a prospective, observational translational study of patients undergoing major abdominal wall reconstruction with primary fascial closure. The project integrates perioperative cytokine profiling, direct measurement of intra-abdominal pressure, and detailed clinical outcomes to define the biol...
What is the current status of trial NCT07422584?
This trial is currently recruiting. The enrollment target is 25 participants. The study started on 2026-02-03. Estimated completion is 2027-03-05.
What conditions does trial NCT07422584 study?
This clinical trial studies the following conditions: Incisional Ventral Hernia.
What interventions are being tested in trial NCT07422584?
The interventions under investigation include: Not applicable- observational study (OTHER).
Who is sponsoring clinical trial NCT07422584?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07422584 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI